Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
317 studies found for:    Open Studies | wake forest
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Reducing Suicidal Ideation Through Insomnia Treatment
Conditions: Insomnia;   Depression;   Suicidal Ideation
Interventions: Drug: Zolpidem-CR;   Drug: Placebo
2 Recruiting Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Condition: Neuropathic Pain
Interventions: Drug: Donepezil;   Drug: Placebo
3 Recruiting Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
Condition: Intracerebral Hemorrhage
Intervention: Drug: Nicardipine hydrochloride
4 Recruiting Muscle Progenitor Cell Therapy for Urinary Incontinence
Condition: Urinary Incontinence
Intervention: Biological: Autologous Muscle Progenitor Cells
5 Recruiting Dystonia Coalition Projects
Conditions: Dystonia;   Voice Disorders
Intervention:
6 Recruiting A Study of the Safety and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients
Conditions: CMV;   Adenoviruses (AdV);   Epstein-Barr (EBV);   Human Herpes Virus Type 6 (HHV6);   BK Virus (BKV)
Intervention: Drug: Brincidofovir (CMX001)
7 Not yet recruiting Apathy in Dementia Methylphenidate Trial 2
Conditions: Apathy;   Alzheimer's Disease
Interventions: Drug: Methylphenidate;   Drug: Placebo
8 Recruiting Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
Condition: Super-refractory Status Epilepticus
Intervention: Drug: SAGE-547
9 Recruiting A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures
Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation;   Procedure: External Fixation;   Procedure: Percutaneous Pinning;   Procedure: Closed Reduction and casting
10 Recruiting Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Conditions: End-Stage Renal Disease;   Kidney Failure;   Kidney Transplantation
Interventions: Drug: Anti-thymocyte Globulin (rabbit) (rATG) (Thymoglobulin);   Drug: Divided-dose Thymoglobulin administration
11 Recruiting Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: NeuRx® Diaphragm Pacing System™ (DPS)
12 Recruiting Study of COPD Subgroups and Biomarkers
Conditions: COPD;   Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis;   Emphysema
Intervention:
13 Recruiting A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Condition: Colon Cancer
Intervention:
14 Recruiting A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Conditions: Hematologic Malignancies;   Certain:;   Inherited Disorders of Metabolism;   Inherited Abnormalities of Erythrocyte Differentiation or Function;   Inherited Abnormalities of Platelets;   Disorders of the Immune System;   Histiocytic Disorders;   X-linked Adrenoleukodystrophy;   Primary Immunodeficiency Diseases;   Bone Marrow Failure;   Beta-thalassemia
Intervention: Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
15 Recruiting A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Condition: B-cell Chronic Lymphocytic Leukemia
Interventions: Drug: Lenalidomide;   Drug: Placebo
16 Recruiting Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Conditions: Alzheimer Disease;   Mild Cognitive Impairment;   Neurodegenerative Diseases
Intervention: Drug: Florbetapir F 18
17 Recruiting Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide
18 Recruiting A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: CC-220;   Drug: Placebo
19 Recruiting The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
Conditions: Delirium;   Impaired Cognition;   Long Term Psychologic Disorders
Interventions: Drug: Haloperidol;   Drug: Ziprasidone;   Drug: Placebo
20 Not yet recruiting Proof-of-Concept Trial of LY2456302 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
Condition: Treatment Resistant Depression
Interventions: Drug: LY2456302;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years